Recent Finacing
Recent Raise
Sinopia Biosciences operates LEADS, a computational drug-discovery platform combining metabolomics, multi-omics, high-throughput screening, AI/ML, predictive modeling and network biology to identify therapeutic targets and candidates for oral mucositis.
